Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
Open-market buys, last 90 days
$884,752
in 1 filing
Open-market sales, last 90 days
$1,763,410
in 5 filings, $1.8M under 10b5-1 plans

Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-07-06 Loose Christopher R. Chief Scientific Officer Sale 10b5-1 −1,384 $0.34 $471 198,666
2023-07-06 Mitrano Richard J. VP Finance & Operations Sale 10b5-1 −224 $0.35 $78 31,529
2023-07-06 Mitrano Richard J. VP Finance & Operations Option exercise 10b5-1 +758 32,287
2023-07-06 Mitrano Richard J. VP Finance & Operations Option exercise · Restricted Stock Unit 10b5-1 −758 23,484
2023-07-06 Lucchino David L. President and CEO Sale −2,773 $0.34 $943 429,739
2023-07-06 Lucchino David L. President and CEO Option exercise +9,091 438,830
2023-07-06 Lucchino David L. President and CEO Option exercise · Restricted Stock Unit −9,091 281,818
2023-07-06 Loose Christopher R. Chief Scientific Officer Option exercise 10b5-1 +4,546 59,142
2023-07-06 Loose Christopher R. Chief Scientific Officer Sale 10b5-1 −1,384 $0.34 $471 57,758
2023-07-06 Loose Christopher R. Chief Scientific Officer Option exercise · Restricted Stock Unit 10b5-1 −4,546 140,908
2023-07-05 Mitrano Richard J. VP Finance & Operations Option exercise 10b5-1 +758 31,753
2023-07-05 Mitrano Richard J. VP Finance & Operations Option exercise · Restricted Stock Unit 10b5-1 −758 24,242
2023-07-05 Lucchino David L. President and CEO Option exercise +9,091 432,512
2023-07-05 Lucchino David L. President and CEO Option exercise · Restricted Stock Unit −9,091 290,909
2023-07-05 Loose Christopher R. Chief Scientific Officer Option exercise 10b5-1 +4,546 54,596
2023-07-05 Loose Christopher R. Chief Scientific Officer Option exercise · Restricted Stock Unit 10b5-1 −4,546 145,454
2023-07-04 Mitrano Richard J. VP Finance & Operations Option exercise 10b5-1 +25,000 55,995
2023-07-04 Mitrano Richard J. VP Finance & Operations Option exercise · Restricted Stock Unit 10b5-1 −25,000 0
2023-07-04 Lucchino David L. President and CEO Option exercise 10b5-1 +300,000 723,421
2023-07-04 Lucchino David L. President and CEO Option exercise · Restricted Stock Units 10b5-1 −300,000 0

Page 15 of 23 · 441 trades